A Trial To Find Out If Vidutolimod Together With Cemiplimab Is Safe And If It Works In Adult Participants With Advanced Cancer Or Metastatic Cancer
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Merkel Cell Carcinoma|Cutaneous Squamous Cell Carcinoma|Basal Cell Carcinoma|Triple Negative Breast Cancer|Non-Small Cell Lung Cancer|Oropharynx Squamous Cell Carcinoma
Interventions: DRUG: vidutolimod|DRUG: cemiplimab
Sponsor: Regeneron Pharmaceuticals